Join PRA Health Sciences Vice President, Investigator Relations, Dr. Martin Lee, as he explores evidence based and site focused recruitment techniques for optimizing and accelerating clinical trial enrollment.
We’ve contributed to the successful approval of eight marketed cardio-metabolic drugs.
Easing the Rare Disease Patient’s Burden in Clinical Trials with Innovative Technology
In this webinar, you will learn how technology can influence rare disease clinical study design, increase the speed of research and thereby reduce…
State-of-the-art Clinical Facilities
We provide end-to-end bioanalytical support from Pre-clinical to Phase IV studies. At PRA, our laboratories are managed, staffed, and supported by…